| scholarly article | Q13442814 |
| P50 | author | Daniel G Colley | Q85315375 |
| William Evan Secor | Q87404657 | ||
| Pauline N M Mwinzi | Q114737953 | ||
| Diana M S Karanja | Q114737958 | ||
| Carla L. Black | Q115973906 | ||
| Erick M O Muok | Q124652188 | ||
| P2093 | author name string | Jennifer M Carter | |
| P2860 | cites work | Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni | Q21092289 |
| The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice | Q28590703 | ||
| Molecular blocking of CD23 supports its role in the pathogenesis of arthritis | Q33417262 | ||
| Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans | Q34492595 | ||
| Signaling in transitional type 2 B cells is critical for peripheral B-cell development | Q35666703 | ||
| Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments | Q37085574 | ||
| Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages | Q37119685 | ||
| Schistosoma mansoni in infants (aged < 3 years) along the Ugandan shoreline of Lake Victoria. | Q38879409 | ||
| Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns | Q38886898 | ||
| Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management | Q39191146 | ||
| Seeking the ghost of worms past | Q39602856 | ||
| CD21 is a ligand for CD23 and regulates IgE production | Q41609094 | ||
| Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study | Q44145263 | ||
| Chemotherapy-induced, age-related changes in antischistosome antibody responses | Q44468424 | ||
| Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment. | Q44616980 | ||
| Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya | Q44908498 | ||
| Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection | Q46660033 | ||
| Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection | Q47887339 | ||
| A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. | Q50925254 | ||
| A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. | Q52878870 | ||
| Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. | Q53545743 | ||
| Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. | Q53883376 | ||
| Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. | Q54147190 | ||
| Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. | Q54268997 | ||
| Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. | Q55052416 | ||
| Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm | Q58312867 | ||
| Age-related changes in human blood lymphocyte subpopulations | Q67744458 | ||
| Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development | Q72332757 | ||
| The control of schistosomiasis. Second report of the WHO Expert Committee | Q72809028 | ||
| Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment | Q73668677 | ||
| A novel B cell-mediated transport of IgE-immune complexes to the follicle of the spleen | Q81206525 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Kenya | Q114 |
| Schistosoma mansoni | Q2324689 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 399-405 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni | |
| P478 | volume | 202 |
| Q34626114 | Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis |
| Q35088439 | Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil |
| Q35191872 | CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells |
| Q34500892 | Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray |
| Q53697118 | Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses. |
| Q35272747 | Efficacy and safety of arachidonic acid for treatment of school-age children in Schistosoma mansoni high-endemicity regions |
| Q26863301 | Helminth parasite proteomics: from experimental models to human infections |
| Q28542932 | Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis |
| Q46430580 | Host immunity, nutrition and coinfection alter longitudinal infection patterns of schistosomes in a free ranging African buffalo population. |
| Q41373939 | Immuno-evasive tactics by schistosomes identify an effective allergy preventative |
| Q36942712 | Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection |
| Q34782228 | Immunology of human schistosomiasis |
| Q27305172 | Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens |
| Q50532009 | Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study. |
| Q33611746 | Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases |
| Q36283976 | Innate immunostimulatory properties of allergens and their relevance to food allergy |
| Q28543650 | No apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission area |
| Q50114695 | Paediatric schistosomiasis: What we know and what we need to know. |
| Q37994231 | Parasite glycans and antibody-mediated immune responses in Schistosoma infection |
| Q24635389 | Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic |
| Q28541406 | Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium |
| Q36057144 | Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium |
| Q34654313 | Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils |
| Q33828497 | Regulatory and activated T cells in human Schistosoma haematobium infections |
| Q34626126 | Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis? |
| Q36158825 | Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies |
| Q28478162 | Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel |
| Q50966400 | Schistosomiasis therapeutics: whats in the pipeline? |
| Q24598949 | Schistosomiasis vaccines |
| Q35230008 | Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni. |
| Q37226715 | Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infection |
| Q57152572 | The Interdependence between Schistosome Transmission and Protective Immunity |
| Q40079529 | Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens |
Search more.